Market research
53S1.F The Supreme Cannabis Company, Inc
F EUR Not available
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 169M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 2.19
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- Not available
- Market cap
- 169M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 2.19
About
About The Supreme Cannabis Company, Inc
The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada. As of June 22, 2021, The Supreme Cannabis Company, Inc. operates as a subsidiary of Canopy Growth Corporation.
Research context
The Supreme Cannabis Company, Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 53S1.F discussion.
5 years, 7 months ago
The Supreme Cannabis Company, Inc is currently in a long term uptrend where the price is trading 35.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
The Supreme Cannabis Company, Inc's total revenue rose by 102.1% to $18M since the same quarter in the previous year.
Its net income has increased by 54.3% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 99.0% to $-352K since the same quarter in the previous year.
Based on the above factors, The Supreme Cannabis Company, Inc gets an overall score of 5/5.